Stay informed with the latest updates for the inheritable blood disorders community. Industry FDA Gives Breakthrough Designation to Hemophilia Gene TherapyFeb 1, 2017 Industry GenVec and WU Enter Hemophilia Therapies AgreementJan 12, 2017 Industry FDA will Review LFB's Application for Recombinant Factor VIIa TherapyJan 11, 2017 Industry Sangamo Receives FDA Approval for Hemophilia A Gene Therapy TrialJan 10, 2017 Industry BioMarin’s Hemophilia A Gene Therapy Trial Demonstrates Increased FVIII…Jan 9, 2017 Industry Updated: Genentech's Subcutaneous Therapy Performing Well in StudyJan 3, 2017 Industry Octapharma Reports Data on Inhibitor Rates in Nuwiq® Trial Dec 22, 2016 Industry UniQure’s Hemophilia B Gene Therapy Performs Well in Clinical TrialDec 19, 2016 Industry CSL Behring Presents Data on Therapeutic Potential of Idelvion® Dec 15, 2016 Industry Biogen Reports ELOCTATE™ Shows Positive Implications for Quality of LifeDec 14, 2016 Industry Alnylam Reports Progress on Investigational Subcutaneous Hemophilia…Dec 13, 2016 Industry Spark Reports Positive Data from Hemophilia B Gene Therapy ProgramDec 7, 2016 Industry Sangamo Reports Hemophilia A Gene Therapy Progress at ASHDec 7, 2016 Industry Octapharma Announces Two New Clinical TrialsNov 28, 2016 Industry Sangamo’s SB-FIX Receives FDA's Orphan Drug StatusSep 8, 2016 Pagination First page Previous page … Page 9 Page 10 Page 11 Page 12 Current page 13 Page 14 Page 15 Page 16 Page 17 … Next page Last page
